Carson Wealth (CWM LLC)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
Carson Wealth (CWM LLC)'s CERE Position: Q3 2024 in Review
Carson Wealth (CWM LLC) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 225 shares — an estimated $9K sold.
Carson Wealth (CWM LLC) first reported a position in CERE in Q1 2022 and held it in 10 quarters. The position peaked at $9K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.
- Carson Wealth (CWM LLC) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 225 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $9K.
- Carson Wealth (CWM LLC) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
- Carson Wealth (CWM LLC)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $9K in Q2 2024.
- 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.